Looking at the results for Woulgan Biogel presented at a seminar last month, the product doesn't seem to come close to VG. See p6 of
http://www.newsweb.no/newsweb/attachment.do?name=Carnegie_Stockholm_2012.pdf&attId=103275
By comparison, VG was effective on wounds that hadn't responded to standard treatment.
Interesting about the CE filing though.
"Submitted dossier for CE mark as an advanced medical device (Class III, Rule 13)...Approval expected by the end of first half 2013"
- Forums
- ASX - By Stock
- TIS
- competition?
competition?, page-3
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)